The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.

Dermatologists have warned that applying adult skincare products and alcohol-based creams on babies puts them at risk of skin ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer ...

Two studies assessed the quality and accuracy of ChatGPT recommendations for atopic dermatitis based on their concordance with clinical guidelines.

Both body creams and lotions hydrate skin, but they have a few key differences. The main is consistency. Here’s how to tell ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical foam 0.3%, and $2.5M for ZORYVE cream 0.15%; sales growth ...

Whatever TikTok trends or buzzy skin-care ingredients are out there, heed this piece of advice: Don't compromise your barrier ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Does your skin feel as dry as a desert no matter how much moisturiser you use? It’s time to step up your skincare game.